查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1790398

美国电生理映射消融设备市场规模、份额和趋势分析报告：按程序类型、产品范围和细分市场预测，2025 年至 2033 年

U.S. Electrophysiology Mapping And Ablation Devices Market Size, Share & Trends Analysis Report By Procedure Type (EP Ablation Procedures, Stand-Alone EP Diagnostic Procedures), By Product Coverage, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

美国电生理映射消融设备市场摘要

美国电生理标测消融设备市场规模预计在 2024 年为 104.7 亿美元，预计到 2033 年将达到 231.1 亿美元，2025 年至 2033 年的复合年增长率为 8.05%。美国采用电生理 (EP) 标测消融设备是由于心房颤动和其他复杂心律不整的负担日益加重，尤其是在老化和高风险族群中。

美国肥胖、高血压和糖尿病发病率的上升导致外科手术数量增加，并加速了对先进电生理 (EP) 诊断和治疗技术的需求。根据美国疾病管制与预防中心 (CDC) 预测，到 2030 年，美国将有约 1,210 万人受心房颤动影响。美国心律不整（尤其是心房颤动）的负担日益加重，推动了电生理 (EP) 标测和消融设备的普及。

随着医院和专科中心扩大其心臟病学项目，对能够更快、更准确诊断和更有针对性治疗的工具的需求日益增长。 2020年3月，《临床心臟病学》杂誌发表了一项对美国心律不整相关死亡的25年分析报告，报告称，1999年至2023年，35岁及以上成年人死亡人数为505万。死亡率从1999年到2009年下降，随后稳定上升，在2021年新冠疫情期间达到顶峰，随后略有下降。

技术进步仍然是市场成长的关键驱动力。 3D 映射系统、脉衝电场消融平台和人工智慧导航等创新技术正在提高准确性并降低手术风险。这些技术在美国医疗保健提供者中越来越受到青睐，他们致力于简化工作流程、改善治疗效果，并在竞争日益激烈的电生理领域中占据优势。 2025 年 6 月，飞利浦 Medisize 推出了 TheraVolt，这是第一个专为高压、高针数电生理 (EP) 映射和消融设备量身定制的品牌医疗连接器系列。 TheraVolt 旨在支援脉衝场消融治疗，提供可客製化、可消毒的解决方案，具有高密度整合和平台灵活性。

美国日益增强的认知和筛检力度正在加速 EP 技术的使用。社区健康计画、健康系统主导的推广以及主动心律监测有助于及早发现心律不整。随着越来越多的患者在出现併发症之前得到诊断，对诊断和治疗 EP 程序及支援设备的需求持续增长。 2025 年 7 月，PCNA 发布了一份白皮书，评估了马里兰州巴尔的摩市以地区为基础心房颤动 (AFib) 和高血压筛检倡议的成功经验。该报告强调了早期和微创诊断解决方案的必要性，因为心房颤动由于其发作性而无法充分诊断，预计到 2030 年患病人数将增至 1210 万人。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国电生理映射消融设备市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 美国电生理映射消融设备市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章美国电生理映射消融设备市场：程序类型估计和趋势分析

  • 美国电生理标测消融设备：手术类型仪表板
  • 美国电生理标测消融设备：手术类型变异分析
  • 美国电生理映射消融设备市场规模、预测和趋势分析（按程序类型）（2021-2033 年）
  • EP消融手术
    • 按指示
    • 心房颤动
    • 右心房扑动
    • 左心房扑动
    • 房室结迴旋性心搏过速（AVNRT）
    • 右房心搏过速（AT）
    • 左房心搏过速（AT）
    • 右侧沃尔夫-巴金森-怀特氏症候群（WPW）
    • 左侧沃尔夫-帕金森-怀特症候群（WPW）
    • 右心室心搏过速（VT）
    • 左心室心搏过速（VT）
    • 产品类型
  • 独立 EP 诊断程序

第五章美国电生理映射消融设备市场：产品范围估计与趋势分析

  • 美国电生理映射消融设备市场：产品规格仪表板
  • 美国电生理映射消融设备市场：产品范围变化分析
  • 美国电生理映射消融设备市场规模、预测和趋势分析（按产品范围）（2021-2033 年）
  • 地图和实验室系统
    • X射线系统
    • 地图系统
    • EP录音系统
    • ICE系统
    • 射频消融发生器
    • 脉衝电场消融发生器
    • 冷冻消融发生器
  • 诊断导管
    • 传统的
    • 高级型
    • 超音波
  • 消融导管
    • 局部消融导管
    • 球囊消融导管
  • 附属设备
    • 长期植入
    • 房间隔穿刺针
    • 导航配件

第六章 竞争态势

  • 主要製造商的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
    • 主要经销商和通路合作伙伴名单
    • Key customers
    • Key company market share analysis, 2024
    • Siemens Healthineers
    • Koninklijke Philips NV
    • Abbott
    • Johnson &Johnson（Biosense Webster）
    • GE HealthCare
    • Boston Scientific Corporation
    • Medtronic
    • Biotronik SE &Co KG
    • MicroPort Scientific Corporation
    • CardioFocus, Inc.
Product Code: GVR-4-68040-694-8

U.S. Electrophysiology Mapping and Ablation Devices Market Summary

The U.S. electrophysiology mapping and ablation devices market size was estimated at USD 10.47 billion in 2024 and is projected to reach USD 23.11 billion by 2033, growing at a CAGR of 8.05% from 2025 to 2033. Widespread use of electrophysiology (EP) mapping and ablation devices in the U.S. is being driven by the escalating burden of atrial fibrillation and other complex arrhythmias, particularly among aging and at-risk populations.

As clinical guidelines increasingly favor early interventional treatment, hospitals and ambulatory centers are expanding their EP capabilities.Rising obesity rates, hypertension, and diabetes prevalence in the U.S. are contributing to increased procedure volumes and accelerating the demand for advanced diagnostic and therapeutic EP technologies. According to the CDC, approximately 12.1 million people in the U.S. will be suffering from atrial fibrillation by 2030. The growing burden of arrhythmias in the U.S., particularly atrial fibrillation, is driving increased adoption of electrophysiology (EP) mapping and ablation devices.

As hospitals and specialty centers expand their cardiac programs, there is a rising demand for tools that enable faster, more accurate diagnosis and targeted treatment. In March 202, Clinical Cardiology published a 25-year analysis of arrhythmia-related deaths in the U.S., reporting 5.05 million deaths among adults aged 35+ from 1999-2023. Mortality fell from 1999 to 2009, then rose steadily, peaking in 2021 during the COVID-19 pandemic before declining slightly.

Technological advancement remains a key driver of market growth. Innovations in 3D mapping systems, pulsed field ablation platforms, and AI-guided navigation are improving precision and reducing procedural risk. These technologies are gaining traction among U.S. providers seeking to streamline workflows, enhance outcomes, and stay ahead in an increasingly competitive electrophysiology landscape. In June 2025, Phillips Medisize launched TheraVolt, its first branded line of medical connectors tailored for high-voltage, high pin-count electrophysiology (EP) mapping and ablation devices. Designed to support pulsed field ablation therapies, TheraVolt offers customizable, sterilization-compatible solutions with high-density integration and platform flexibility.

Growing awareness and screening initiatives across the U.S. are accelerating the use of EP technologies. Community health programs, health system-led outreach, and proactive rhythm monitoring are helping identify arrhythmias earlier. As more patients are diagnosed before complications arise, demand for diagnostic and therapeutic EP procedures and the devices that support them continues to rise. In July 2025, a white paper published by PCNA evaluated the outcomes of a community-based screening initiative targeting atrial fibrillation (AFib) and hypertension in Baltimore, Maryland. The report noted that AFib remains underdiagnosed due to its episodic symptoms, underscoring the growing need for early, minimally invasive diagnostic solutions as cases are projected to rise to 12.1 million by 2030.

U.S. Electrophysiology Mapping And Ablation Devices Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. electrophysiology mapping and ablation devices market report based on procedure type and product coverage:

  • Procedure Type Outlook (Revenue, USD Million, 2021 - 2033)
  • EP Ablation Procedures
    • By Indication
    • Atrial Fibrillation
    • Paroxysmal AF
    • Persistent AF
    • Long standing persistent/permanent
    • Right Atrial Flutter
    • Left Atrial Flutter
    • Atrioventricular Nodal Reentry Tachycardia (AVNRT)
    • Right Atrial Tachycardia (AT)
    • Left Atrial Tachycardia (AT)
    • Right Wolff-Parkinson-White (WPW)
    • Left Wolff-Parkinson-White (WPW)
    • Right Ventricular Tachycardia (VT)
    • Left Ventricular Tachycardia (VT)
  • Stand-Alone EP Diagnostic Procedures
    • By Product Type
    • Focal Ablation Catheter
    • Radiofrequency (RF)
    • Conventional
    • Irrigated-tip
    • Contact-Force-Sensing
    • Standard
    • Alternative Energy
    • Pulsed Field Ablation
    • Balloon Ablation Catheters
  • Product Coverage Outlook (Revenue, USD Million, 2021 - 2033)
  • Mapping & Lab Systems
    • X-Ray Systems
    • Mapping Systems
    • EP Recording Systems
    • ICE Systems
    • RF Ablation Generators
    • Pulsed Field Ablation Generators
    • Cryoablation Generators
  • Diagnostic Catheters
    • Conventional
    • Fixed
    • Steerable
    • Advanced
    • Ultrasound
  • Ablation Catheters
    • Focal Ablation Catheter
    • Radiofrequency (RF)
    • Conventional
    • Irrigated-tip
    • Contact-Force-Sensing
    • Standard
    • Alternative Energy
    • Pulsed Field Ablation
    • Balloon Ablation Catheters
  • Accessory Devices
    • Long Introducer Sheaths
    • Fixed
    • Steerable
    • Transseptal Needles
    • Conventional
    • RF
    • Navigational Accessories

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Procedure Type
    • 1.2.2. Product Coverage
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Procedure Type Segment
    • 2.2.2. Product Coverage Segment
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Electrophysiology Mapping and Ablation Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of cardiac arrhythmias
      • 3.2.1.2. Ongoing technological innovation in EP mapping and ablation
      • 3.2.1.3. Expanding awareness and adoption of AFib screening programs
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of advanced EP systems and ablation procedures
      • 3.2.2.2. Complex and evolving regulatory compliance requirements
  • 3.3. U.S. Electrophysiology Mapping and Ablation Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Social landscape
      • 3.3.2.5. Legal landscape
      • 3.3.2.6. Environmental landscape

Chapter 4. U.S. Electrophysiology Mapping and Ablation Devices Market: Procedure Type Estimates & Trend Analysis

  • 4.1. U.S. Electrophysiology Mapping and Ablation Devices Market: Procedure Type Dashboard
  • 4.2. U.S. Electrophysiology Mapping and Ablation Devices Market: Procedure Type Movement Analysis
  • 4.3. U.S. Electrophysiology Mapping and Ablation Devices Market Size & Forecasts and Trend Analysis, by Procedure Type, 2021 - 2033 (USD Million)
  • 4.4. EP Ablation Procedures
    • 4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. By Indication
    • 4.4.3. Atrial Fibrillation
      • 4.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.2. Paroxysmal AF
        • 4.4.3.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.3. Persistent AF
        • 4.4.3.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.4. Long standing persistent/permanent
        • 4.4.3.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Right Atrial Flutter
      • 4.4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.5. Left Atrial Flutter
      • 4.4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.6. Atrioventricular Nodal Reentry Tachycardia (AVNRT)
      • 4.4.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.7. Right Atrial Tachycardia (AT)
      • 4.4.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.8. Left Atrial Tachycardia (AT)
      • 4.4.8.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.9. Right Wolff-Parkinson-White (WPW)
      • 4.4.9.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.10. Left Wolff-Parkinson-White (WPW)
      • 4.4.10.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.11. Right Ventricular Tachycardia (VT)
      • 4.4.11.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.12. Left Ventricular Tachycardia (VT)
      • 4.4.12.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.13. By Product Type
      • 4.4.13.1. Focal ablation catheter
        • 4.4.13.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.13.1.2. Radiofrequency (RF)
          • 4.4.13.1.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.4.13.1.2.2. Conventional
          • 4.4.13.1.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.4.13.1.2.3. Irrigated-tip
            • 4.4.13.1.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
            • 4.4.13.1.2.3.2. Contact-force-sensing
            • 4.4.13.1.2.3.3. Standard
        • 4.4.13.1.3. Alternative energy
          • 4.4.13.1.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.13.1.4. Pulsed field ablation
          • 4.4.13.1.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.13.2. Balloon ablation catheters
        • 4.4.13.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Stand-Alone EP Diagnostic Procedures
    • 4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Electrophysiology Mapping and Ablation Devices Market: Product Coverage Estimates & Trend Analysis

  • 5.1. U.S. Electrophysiology Mapping and Ablation Devices Market: Product Coverage Dashboard
  • 5.2. U.S. Electrophysiology Mapping and Ablation Devices Market: Product Coverage Movement Analysis
  • 5.3. U.S. Electrophysiology Mapping and Ablation Devices Market Size & Forecasts and Trend Analysis, by Product Coverage, 2021 - 2033 (USD Million)
  • 5.4. Mapping & Lab Systems
    • 5.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.2. X-Ray Systems
      • 5.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.3. Mapping Systems
      • 5.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.4. EP Recording Systems
      • 5.4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.5. ICE Systems
      • 5.4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.6. RF Ablation Generators
      • 5.4.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.7. Pulsed Field Ablation Generators
      • 5.4.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.8. Cryoablation Generators
      • 5.4.8.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Diagnostic Catheters
    • 5.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.5.2. Conventional
      • 5.5.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.5.2.2. Fixed
        • 5.5.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.5.2.3. Steerable
        • 5.5.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.5.3. Advanced
      • 5.5.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.5.4. Ultrasound
      • 5.5.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Ablation Catheters
    • 5.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.6.2. Focal Ablation Catheter
      • 5.6.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.6.2.2. Radiofrequency (RF)
        • 5.6.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 5.6.2.2.2. Conventional
          • 5.6.2.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 5.6.2.2.3. Irrigated-tip
          • 5.6.2.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
          • 5.6.2.2.3.2. Contact-force-sensing
            • 5.6.2.2.3.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
          • 5.6.2.2.3.3. Standard
            • 5.6.2.2.3.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.6.2.3. Alternative energy
        • 5.6.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.6.2.4. Pulsed field ablation
        • 5.6.2.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.6.3. Balloon Ablation Catheters
      • 5.6.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.7. Accessory Devices
    • 5.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.7.2. Long Introducer Sheaths
      • 5.7.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.7.2.2. Fixed
        • 5.7.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.7.2.3. Steerable
        • 5.7.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.7.3. Transseptal Needles
      • 5.7.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.7.3.2. Conventional
        • 5.7.3.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.7.3.3. RF
        • 5.7.3.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.7.4. Navigational Accessories
      • 5.7.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company market share analysis, 2024
    • 6.3.4. Siemens Healthineers
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Product benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Koninklijke Philips N.V.
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Product benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Abbott
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Product benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Johnson & Johnson (Biosense Webster)
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Product benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. GE HealthCare
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Product benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. Boston Scientific Corporation
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Product benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Medtronic
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Product benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. Biotronik SE & Co KG
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Product benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. MicroPort Scientific Corporation
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Product benchmarking
      • 6.3.12.4. Strategic initiatives
    • 6.3.13. CardioFocus, Inc.
      • 6.3.13.1. Company overview
      • 6.3.13.2. Financial performance
      • 6.3.13.3. Product benchmarking
      • 6.3.13.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. U.S. electrophysiology mapping and ablation devices market, by procedure type, 2021 - 2033 (USD Million)
  • Table 4. U.S. electrophysiology mapping and ablation devices market, by product coverage, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. electrophysiology mapping and ablation devices market: outlook
  • Fig. 9 U.S. electrophysiology (EP) mapping and ablation devices competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Ancillary market outlook
  • Fig. 12 U.S. electrophysiology mapping and ablation devices market driver impact
  • Fig. 13 U.S. electrophysiology mapping and ablation devices market restraint impact
  • Fig. 14 Porter's Analysis
  • Fig. 15 PESTLE Analysis
  • Fig. 16 U.S. electrophysiology mapping and ablation devices market: Procedure type movement analysis
  • Fig. 17 U.S. electrophysiology mapping and ablation devices market: Procedure type outlook and key takeaways
  • Fig. 18 EP ablation procedures market, 2021 - 2033 (USD Million)
  • Fig. 19 Atrial fibrillation market, 2021 - 2033 (USD Million)
  • Fig. 20 Paroxysmal AF market, 2021 - 2033 (USD Million)
  • Fig. 21 Persistent AF market, 2021 - 2033 (USD Million)
  • Fig. 22 Long standing persistent/permanent market, 2021 - 2033 (USD Million)
  • Fig. 23 Right atrial flutter market, 2021 - 2033 (USD Million)
  • Fig. 24 Left atrial flutter market, 2021 - 2033 (USD Million)
  • Fig. 25 Atrioventricular nodal reentry tachycardia (AVNRT) market, 2021 - 2033 (USD Million)
  • Fig. 26 Left atrial tachycardia (AT) market, 2021 - 2033 (USD Million)
  • Fig. 27 Right atrial tachycardia (AT) market, 2021 - 2033 (USD Million)
  • Fig. 28 Right wolff-parkinson-white (WPW) market, 2021 - 2033 (USD Million)
  • Fig. 29 Left wolff-parkinson-white (WPW) market, 2021 - 2033 (USD Million)
  • Fig. 30 Right ventricular tachycardia (VT) market, 2021 - 2033 (USD Million)
  • Fig. 31 Left ventricular tachycardia (VT) market, 2021 - 2033 (USD Million)
  • Fig. 32 Stand-alone EP diagnostic procedures market, 2021 - 2033 (USD Million)
  • Fig. 33 By product type market, 2021 - 2033 (USD Million)
  • Fig. 34 Focal ablation catheter market, 2021 - 2033 (USD Million)
  • Fig. 35 Radiofrequency (RF) market, 2021 - 2033 (USD Million)
  • Fig. 36 Conventional market, 2021 - 2033 (USD Million)
  • Fig. 37 Irrigated-tip market, 2021 - 2033 (USD Million)
  • Fig. 38 Contact-force-sensing market, 2021 - 2033 (USD Million)
  • Fig. 39 Standard market, 2021 - 2033 (USD Million)
  • Fig. 40 Alternative energy market, 2021 - 2033 (USD Million)
  • Fig. 41 Pulsed field ablation market, 2021 - 2033 (USD Million)
  • Fig. 42 Balloon ablation catheters market, 2021 - 2033 (USD Million)
  • Fig. 43 U.S. electrophysiology mapping and ablation devices market: Product coverage movement analysis
  • Fig. 44 U.S. electrophysiology mapping and ablation devices market: Product coverage outlook and key takeaways
  • Fig. 45 Mapping & lab systems market, 2021 - 2033 (USD Million)
  • Fig. 46 X-ray systems market, 2021 - 2033 (USD Million)
  • Fig. 47 Mapping systems market, 2021 - 2033 (USD Million)
  • Fig. 48 EP recording systems market, 2021 - 2033 (USD Million)
  • Fig. 49 ICE systems market, 2021 - 2033 (USD Million)
  • Fig. 50 RF ablation generators market, 2021 - 2033 (USD Million)
  • Fig. 51 Pulsed field ablation generators market, 2021 - 2033 (USD Million)
  • Fig. 52 Cryoablation generators market, 2021 - 2033 (USD Million)
  • Fig. 53 Diagnostic catheters market, 2021 - 2033 (USD Million)
  • Fig. 54 Conventional market, 2021 - 2033 (USD Million)
  • Fig. 55 Fixed market, 2021 - 2033 (USD Million)
  • Fig. 56 Steerable market, 2021 - 2033 (USD Million)
  • Fig. 57 Advanced market, 2021 - 2033 (USD Million)
  • Fig. 58 Ultrasound market, 2021 - 2033 (USD Million)
  • Fig. 59 Ablation catheters market, 2021 - 2033 (USD Million)
  • Fig. 60 Focal ablation catheter market, 2021 - 2033 (USD Million)
  • Fig. 61 Radiofrequency (RF) market, 2021 - 2033 (USD Million)
  • Fig. 62 Conventional market, 2021 - 2033 (USD Million)
  • Fig. 63 Irrigated-tip market, 2021 - 2033 (USD Million)
  • Fig. 64 Contact-force-sensing market, 2021 - 2033 (USD Million)
  • Fig. 65 Standard market, 2021 - 2033 (USD Million)
  • Fig. 66 Alternative energy market, 2021 - 2033 (USD Million)
  • Fig. 67 Pulsed field ablation market, 2021 - 2033 (USD Million)
  • Fig. 68 Balloon ablation catheters market, 2021 - 2033 (USD Million)
  • Fig. 69 Accessory devices market, 2021 - 2033 (USD Million)
  • Fig. 70 Long introducer sheaths market, 2021 - 2033 (USD Million)
  • Fig. 71 Fixed market, 2021 - 2033 (USD Million)
  • Fig. 72 Steerable market, 2021 - 2033 (USD Million)
  • Fig. 73 Transseptal needles market, 2021 - 2033 (USD Million)
  • Fig. 74 Conventional market, 2021 - 2033 (USD Million)
  • Fig. 75 RF market, 2021 - 2033 (USD Million)
  • Fig. 76 Navigational accessories market, 2021 - 2033 (USD Million)
  • Fig. 77 Market participant categorization
  • Fig. 78 Strategy mapping
  • Fig. 79 Key company categorization
  • Fig. 80 Heat map analysis 2024